Filing Details
- Accession Number:
- 0000899243-21-031305
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-08-03 17:16:19
- Reporting Period:
- 2021-08-03
- Accepted Time:
- 2021-08-03 17:16:19
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1850838 | Omega Therapeutics Inc. | OMGA | Biological Products, (No Disgnostic Substances) (2836) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1858748 | Roger Sawhney | C/O Omega Therapeutics, Inc. 20 Acorn Park Drive Cambridge MA 02140 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-08-03 | 2,941 | $17.00 | 2,941 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
